These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38767575)

  • 1. Multifunctional Biomimetic Liposomes with Improved Tumor-Targeting for TNBC Treatment by Combination of Chemotherapy, Antiangiogenesis and Immunotherapy.
    Lan J; Chen L; Li Z; Liu L; Zeng R; He Y; Shen Y; Zhang T; Ding Y
    Adv Healthc Mater; 2024 Oct; 13(26):e2400046. PubMed ID: 38767575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic Nanomodulators With Synergism of Photothermal Therapy and Vessel Normalization for Boosting Potent Anticancer Immunity.
    Lan J; Zeng R; Li Z; Yang X; Liu L; Chen L; Sun L; Shen Y; Zhang T; Ding Y
    Adv Mater; 2024 Oct; 36(40):e2408511. PubMed ID: 39180264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes.
    Xia J; Zhang S; Zhang R; Wang A; Zhu Y; Dong M; Ma S; Hong C; Liu S; Wang D; Wang J
    J Nanobiotechnology; 2022 Sep; 20(1):414. PubMed ID: 36109762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yang R; Lu M; Ming L; Chen Y; Cheng K; Zhou J; Jiang S; Lin Z; Chen D
    Int J Nanomedicine; 2020; 15():9061-9074. PubMed ID: 33239874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy.
    Duan W; Shen Q; Ju L; Huang Z; Geng J; Wu Q; Yu C; Wei J
    ACS Appl Mater Interfaces; 2024 Aug; 16(34):45523-45536. PubMed ID: 39141925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment.
    Jia N; Wang Q; Li W; Chen D; Hu H
    Adv Healthc Mater; 2024 Aug; 13(20):e2400219. PubMed ID: 38657266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
    Doddapaneni R; Patel K; Owaid IH; Singh M
    Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency.
    Wu Y; Chen R; Ni S; Hu K
    J Control Release; 2024 Jun; 370():556-569. PubMed ID: 38697316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer.
    Miao L; Ma H; Dong T; Zhao C; Gao T; Wu T; Xu H; Zhang J
    Drug Dev Ind Pharm; 2023 Jan; 49(1):139-148. PubMed ID: 36881020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade.
    Tu K; Yu Y; Wang Y; Yang T; Hu Q; Qin X; Tu J; Yang C; Kong L; Zhang Z
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39003-39017. PubMed ID: 34433253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer.
    Zhang T; Bai L; You R; Yang M; Chen Q; Cheng Y; Qian Z; Wang Y; Liu Y
    J Mater Chem B; 2024 Jun; 12(22):5465-5478. PubMed ID: 38742364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Treatment of Triple-Negative Breast Cancer Through Gambogic Acid-Loaded Mesoporous Polydopamine.
    Liu J; Liu H; Huang S; Peng H; Li J; Tu K; Tan S; Xie R; Lei L; Yue Q; Gao H; Cai L
    Small; 2024 Aug; 20(31):e2309583. PubMed ID: 38446095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy.
    Bai L; Liu H; You R; Jiang X; Zhang T; Li Y; Shan T; Qian Z; Wang Y; Liu Y; Li C
    Mol Pharm; 2024 May; 21(5):2148-2162. PubMed ID: 38536949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.
    Wang F; Li Y; Jiang H; Li C; Li Z; Qi C; Li Z; Gao Z; Zhang B; Wu J
    Int J Nanomedicine; 2021; 16():4001-4016. PubMed ID: 34135585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
    Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
    Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
    Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.